An overview of systematic reviews and meta-analyses of Withania somnifera
Authors: Dar PA, Singh R, Malik AH.
Study Background & Rationale
This overview aggregated and evaluated published systematic reviews and meta-analyses analyzing the clinical efficacy, active compounds, and safety margins of Withania somnifera.
Intervention Protocol
Aggregate evaluation of multiple clinical cohorts taking standardized extracts across a wide age and dosing spectrum.
Key Academic Findings
- 01.Validated a consistent correlation between Withania somnifera and HPA-axis downregulation.
- 02.Indicated cognitive support and neuroprotective characteristics across preclinical and human studies.
- 03.Confirmed favorable safety and tolerability scores when taken in standard daily dosages.
📊 Primary Outcome
Validated consistent stress reduction, neuroprotection, and physical endurance outcomes.
🔬 Understanding the Evidence
Aggregated evidence supports the adaptogenic role of Ashwagandha as a stress-mitigating and cognitive-supporting compound.
Detailed Analysis
This meta-review compiles the evidence base from several clinical trials, confirming that Withania somnifera exhibits stress-mitigating properties.
⚠️ Research Integrity Notice
This is a plain-language summary of a published study for educational purposes. It is not a substitute for professional medical advice or direct consultation of the original peer-reviewed paper.
Receive The Wellness Research Digest
Join 45,000+ health-conscious readers. Get one research-backed protocol and a breakdown of the latest studies directly to your inbox every Sunday.
🔒 Zero Spam. Unsubscribe with one click. Direct study citations only.